Wang Xi-Wen, Zhong Tian-Yu, Xiong Yun-Hui, Lin Hai-Bo, Liu Qing-Yi
Bao'an Maternal and Child Health Hospital, Shenzhen, China.
Asian Pac J Cancer Prev. 2012;13(8):3717-21. doi: 10.7314/apjcp.2012.13.8.3717.
Any association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk remains inconclusive. For a more precise estimate, we performed the present meta-analysis.
PUBMED, OVID and EMBASE were searched for the studies which met inclusion criteria. Data in all eligible studies were evaluated and extracted by two authors independently. The meta-analysis estimated pooled odds ratio (OR) with 95% confidence interval (CI) for endometrial cancer risk attributable to the CYP1A1 Ile462Val polymorphism.
A total of 7 studies were included in this meta-analysis. The results indicated no association between endometrial cancer risk and the CYP1A1 Ile462Val polymorphism (for Val vs Ile allele model [OR 1.09, 95% CI 0.73-1.62]; for Val.Val vs Ile.Ile genotype model [OR 1.54, 95% CI 0.56-4.23]; for (Ile.Val + Val.Val) vs Ile.Ile genotype model [OR 1.08, 95% CI 0.71-1.63]; for Val.Val vs (Ile.Ile + Ile.Val) genotype model [OR 1.46, 95% CI 0.53-4.04]).
This meta-analysis suggests that there is no association between endometrial cancer risk and the CYP1A1 Ile462Val polymorphism.
细胞色素P450 1A1(CYP1A1)基因Ile462Val多态性与子宫内膜癌风险之间的任何关联仍无定论。为了进行更精确的评估,我们进行了本次荟萃分析。
检索了PUBMED、OVID和EMBASE中符合纳入标准的研究。所有符合条件的研究数据由两位作者独立评估和提取。荟萃分析估计了CYP1A1基因Ile462Val多态性导致子宫内膜癌风险的合并比值比(OR)及其95%置信区间(CI)。
本次荟萃分析共纳入7项研究。结果表明,子宫内膜癌风险与CYP1A1基因Ile462Val多态性之间无关联(Val与Ile等位基因模型[OR 1.09,95%CI 0.73 - 1.62];Val.Val与Ile.Ile基因型模型[OR 1.54,95%CI 0.56 - 4.23];(Ile.Val + Val.Val)与Ile.Ile基因型模型[OR 1.08,95%CI 0.71 - 1.63];Val.Val与(Ile.Ile + Ile.Val)基因型模型[OR 1.46,95%CI 0.53 - 4.04])。
本次荟萃分析表明,子宫内膜癌风险与CYP1A1基因Ile462Val多态性之间无关联。